M. Sharafi-Kolkeshvandi, F. Nikpour / Chinese Chemical Letters 23 (2012) 431–433
433
out under mild conditions which can be used for a variety of substituents on aromatic ring. Good to high yields of the
products were obtained in high purity with simple work-up.
Acknowledgments
We are thankful to the University of Kurdistan Research Council for the partial support of this work.
References
[1] (a) F.D. Therkelsen, A.L. Hansen, E.B. Pedersen, et al. Org. Biomol. Chem. 1 (2003) 2908;
(b) H.Y. Park-Choo, M. Kim, S.K. Lee, et al. Bioorg. Med. Chem. 10 (2002) 517;
(c) T.P. Tran, E.L. Ellsworth, M.A. Stier, et al. Bioorg. Med. Chem. Lett. 14 (2004) 4403.
[2] (a) G.M. Buckley, N. Davies, H.J. Dyke, et al. Bioorg. Med. Chem. Lett. 15 (2005) 751;
(b) V. Colotta, D. Catarzi, F. Varano, et al. Bioorg. Med. Chem. Lett. 14 (2004) 2345;
(c) W. Wouters, C.G.M. Janssen, J.V. Dun, et al. J. Med. Chem. 29 (1986) 1663.
[3] (a) T.P. Tran, E.L. Ellsworth, B.M. Watson, et al. J. Heterocycl. Chem. 42 (2005) 669;
(b) T. Mizuno, T. Iwai, Y. Ishino, Tetrahedron Lett. 45 (2004) 7073;
(c) K.C. Russell, Ch.S. Kim, Ch. Diez, Chem. Eur. J. 6 (2000) 1555;
(d) I.A. Rivero, K. Espinoza, R. Somanathan, Molecules 9 (2004) 609;
(e) T. Okuzumi, E. Nakanishi, T. Tsuji, et al. Tetrahedron 59 (2003) 5603;
(f) D. Schwinn, H. Glatz, W. Bannwarth, Helv. Chem. Acta 86 (2003) 188;
(g) F. Nikpour, T. Paybast, Chem. Lett. 34 (2005) 1438;
(h) T. Mizuno, M. Mihara, T. Nakai, et al. Synthesis (2007) 2524;
(i) K. Malagu, H. Duggan, K. Menear, et al. Bioorg. Med. Chem. Lett. 19 (2009) 5950;
(j) J. Gao, L.N. He, C.X. Miao, et al. Tetrahedron 66 (2010) 4063.
[4] N.A. Lange, F.E. Sheibley, Organic Syntheses Coll., vol. 2, John Wiley & Sons, New York, 1943, p. 79.
[5] (a) T. Mizuno, Y. Ishino, Tetrahedron 58 (2002) 3155;
(b) M.B. Andrus, S.N. Mettath, C. Song, J. Org. Chem. 67 (2002) 8284.
[6] V. Froelicher, J.B. Cohen, J. Chem. Soc. 119 (1921) 1431.
[7] M. Pfleiderer, W. Pfleiderer, Heterocycles 33 (1992) 905.
[8] F. Nikpour, R. Mozafari, T. Paibast, Heterocycles 78 (2009) 1569.
[9] J. Chen, S.K. Spear, J.G. Huddleston, R.D. Rogers, Green Chem. 7 (2005) 64.
[10] R.P. Maskey, M. Shaaban, I. Gru¨n-Wollny, et al. J. Nat. Prod. 67 (2004) 1131.
[11] Melting points were measured with an Electrothermal 9100 apparatus. IR spectra were measured with a Shimadzu IR-460 spectrometer. NMR
spectra were recorded with a Bruker DRX-250 AVANCE instrument (250.1 MHz for 1H and 62.9 MHz for 13C). Chemical shifts are given in
ppm (d) relative to internal TMS, and coupling constants J are reported in Hz. Mass spectra were recorded with an Agilent-5975C mass
spectrometer operating at an ionization potential of 70 eV. PEG with molecular weight 400 was used in reactions. General reaction procedure:
A mixture of an anthranilic acid derivative 1 (1 mmol) in PEG-400 (0.3 mL) and KOCN (1.3 mmol, 0.11 g) was stirred in room temperature for
a short time and then AcOH (2 mmol, 0.11 mL) was added to the mixture and heated for the times as indicated in Table 1. After completion of
the reaction, the precipitate was washed with cold water (three times) to remove the residual of KOCN, AcOH and PEG. The raw products were
washed with 10% NaHCO3 (except for 2g) and then with H2O to remove the trace residual of 1 and then were dried in air. In the case of 2g, the
trace residual of 1e was washed with dilute solution of HCl and then with H2O. The raw products were recrystallized from ethanol, or ethanol/
acetic acid. Quinazoline-2,4(1H,3H)-dione (2a): White powder, mp > 350 8C (Lit. > 350 8C) [4,5], Yield: 95%. 6-Hydroxyquinazoline-
2,4(1H,3H)-dione (2b): White powder, mp: 309–312 8C [6], Yield: 85%. IR (KBr): y 3245 and 3170 (2NH), 1740–1667 (CO) cmÀ1. 1H NMR
(DMSO-d6): d 11.15 (brs, 1H, NH), 10.87 (brs, 1H, NH), 9.64 (brs, 1H, OH), 7.20 (s, 1H–Ar), 7.11–6.89 (m, 2H–Ar). 13C NMR (DMSO-d6): d
ꢀ
163.2, 153.1, 150.5, 133.9, 124.2, 117.1, 115.5, 111.1. EI-MS (70 eV): m/z (%) 178 (M+ , 100). 6-Chloroquinazoline-2,4(1H,3H)-dione (2c):
White powder, mp: 320–323 8C (Lit. > 300 8C) [5], Yield: 85%. 7-Chloroquinazoline-2,4(1H,3H)-dione (2d): White powder, mp: 290–
292 8C, Yield: 90%. R (KBr): y 3305 and 3160 (2NH), 1740 (CO), 1681 (CO) cmÀ1. 1HNMR (DMSO-d6): d 11.35 (brs, 1H, NH), 11.20 (brs,
1H, NH), 7.83 (d, 3JHH = 9.0 Hz, 1H–Ar), 7.17–7.13 (m, 2H–Ar). 13C NMR (DMSO-d6): d 162.5, 150.6, 142.3, 139.7, 129.4, 122.9, 115.1,
113.7. EI-MS (70 eV): m/z (%) 198 [(M+. + 2), 33], 196 (M+., 100). 6-Bromoquinazoline-2,4(1H,3H)-dione (2e): White powder, mp: 318–
321 8C (Lit. > 300 8C) [3j], Yield: 80%. 6,7-Dimethoxyquinazoline-2,4(1H,3H)-dione (2f): White powder, mp: 321–324 8C (Lit. > 300 8C)
[5], Yield: 84%. 8-Methylquinazoline-2,4(1H,3H)-dione (2h): White powder, mp: 296–299 8C (Lit. 297–299 8C) [10], Yield: 82%. Quinazo-
line-2,4(1H,3H)-dione-7-carboxylic acid (2g): White powder, mp: > 350 8C, Yield: 80%. IR (KBr): (3350 (NH), 3305–2500 (NH and OH),
1740 (CO), 1700 (COOH), 1681 (CO) cmÀ1. 1HNMR (DMSO-d6): d 10.88 (brs, 1H, COOH), 10.01 (brs, 2H, 2NH), 8.97–7.62 (m, 3H–Ar). 13
C
ꢀ
NMR (DMSO-d6): d 169.2, 169.1, 166.9, 141.0, 135.6, 131.6, 123.5, 121.4, 120.8. EI-MS (70 eV): m/z (%) 206 (M+ , 100). Pyrido[2,3-
d]pyrimidine-2,4(1H,3H)-dione (2i): White powder, mp: > 350 8C [7], Yield: 78%. R (KBr): y 3250 and 3180 (2NH), 1740 (CO), 1685 (CO)
cmÀ1. 1HNMR (DMSO-d6): d 11.67 (brs, 1H, NH), 11.45 (brs, 1H, NH), 8.59–7.99 (m, 3H–Ar). 13C NMR (DMSO-d6): d 161.5, 150.4, 152.9,
ꢀ
146.3, 139.7, 122.9, 115.1. EI-MS (70 eV): m/z (%) 163 (M+ , 100).